Agilent Snags Life Technologies as Latest Co-Marketing Partner for SureSelect Target-Enrichment System | GenomeWeb

Agilent Technologies and the Applied Biosystems segment of Life Technologies said this week that they have signed a co-marketing agreement related to targeted resequencing.

Under the terms of the agreement, Agilent's SureSelect Target Enrichment System has been optimized for the ABI SOLiD sequencing platform and the firms have agreed to co-market the combined solution.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: transcriptional map of human embryo development, circadian clock genes in acute myeloid leukemia, and more.

The US National Academy of Sciences has announced 84 new members and 21 foreign associates.

The users of file-sharing site Sci-Hub work all around the globe where research is going on, Science's John Bohannon reports.

Researchers link obesity in Labrador retrievers to a deletion in their POMC gene.